CERN-MEDICIS: A unique facility for the production of nonconventional radionuclides for the medical research

Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review


  • Charlotte Duchemin
  • Thierry Stora
  • A. Aubert
  • Ermano Barbero
  • Vincent Barozier
  • Ana-Paula Bernardes
  • Philippe Bertreix
  • D. Burnel
  • Richard Catherall
  • M. Cirilli
  • Thomas Elias Cocolios
  • J. Compte
  • Bernard Crepieux
  • Matthieu Deschamps
  • Kristof Dockx
  • Alexandre Dorsival
  • Valentin N. Fedosseev
  • P. Fernier
  • Roberto Formento-Cavaier
  • Simone Gilardoni
  • Jean-Louis Grenard
  • Ferid Haddad
  • Heinke Reinhard
  • Moazam Khan
  • Ulli Koester
  • Laura Lambert
  • Giordano Lili
  • Lunghi Giacomo
  • Bruce A Marsh
  • Palenzuela Martinez
  • Fabio Pozzi
  • Julien Riegert
  • Sebastian Rothe
  • Francesco Riccardi
  • Nicolas Riggaz
  • Simon Stegemann
  • Zenip Talip
  • Julien Thiboud
  • Nicholas P. van der Meulen
  • Joachim Vollaire
  • Nhat-Tan Vuong

Institutes & Expert groups

  • CERN - Conseil Européen pour la Recherche Nucléaire
  • KUL - Katholieke Universiteit Leuven
  • Pakistan Institute of Nuclear Science and Technology
  • ILL - Institut Laue Langevin
  • PSI - Paul Scherrer Institute
  • UNIMAN - The University of Manchester

Documents & links


CERN-MEDICIS (MEDical Isotopes Collected from ISolde) is a facility at CERN (Switzerland) dedicated to the production of non-conventional radionuclides for research and development in imaging, diagnostics and radiation therapy done at partner institutes. It exploits, in a controlled radiation area suited for the handling of unsealed radioactive sources, a target irradiation station positioned between the High Resolution Separator (HRS) ISOLDE target station and its beam dump, a target remote handling system and a dedicated isotope separator beam line. It irradiates targets with the 1.4 GeV Proton Synchroton Booster (PSB), and also receives activated target materials from external institutes, notably during CERN’s Long Shut-Downs. The irradiated target is heated to high temperatures (up to 2300°C) to allow for the release of the isotopes of interest out of the target which are subsequently ionized. The ions are accelerated and the beam is steered through an offline mass separator. The radionuclide batches are, this way, extracted through mass separation and implanted into a thin metallic collection foil up to an energy of 60 keV. After collection, the isotope source is prepared to be dispatched to biomedical research centers. Since its commissioning in December 2017, the CERN-MEDICIS facility has provided non-conventional medical radionuclides such as Tb-149, Tb-152, Tb-155, Tm-165, Er-169 and Yb-175 with high specific activity, some for the first time, to research institutes and hospitals, being part of the MEDICIS collaboration, for R&D in imaging or treatment.


Original languageEnglish
Title of host publicationMC8: Applications ofAccelerators, Technology Transfer, Industrial Relations and Outreach
Subtitle of host publicationTHVIR13
PublisherJACoW Publishing
ChapterU01 Medical Applications
Number of pages5
ISBN (Print)9783954502134
Publication statusPublished - 10 Oct 2020
Event2020 - IPAC: 11th international particle Accelerator conference - Parc des Expositions, Caen, France
Duration: 10 May 202015 May 2020


Conference2020 - IPAC
OtherAccelerator Conference
Internet address


  • Radionuclides, CERN, Medical isotopes, ISOLDE

ID: 7028784